Jun 4, 2025
Onco-Innovations Limited
‹ Beyond Medical Technologies Closes Second Tranche of Convertible Note Financing
Beyond Medical Technologies Provides Update on 2024 Annual Filings ›
About
Investor Relations
News
Insights
Contact
Subscribe
CSE: DOCT
FSE: 7FM0
OTCQB: DOCKF
